Baxter's $4B bid for Gambro likely to win EU clearance, sources say

07/11/2013 | Reuters

Baxter International's offer to acquire Gambro for $4 billion could be cleared by the European Commission in its decision expected by July 22, according to people familiar with the issue. The news comes after Baxter vowed to divest its global continuous renal replacement therapy unit to allay competition fears.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
Bridgewater, NJ